Live tape
Top 8, mentions 7d9,474TSLA1,996 mentions▲ +0.05GOOGL1,538 mentions▲ +0.05NVDA1,158 mentions▲ +0.07CRWV1,139 mentions▲ +0.03SPCX1,032 mentions▲ +0.07QQQ1,002 mentions▲ +0.04META809 mentions▲ +0.05NBIS800 mentions▲ +0.05

Equity · Healthcare

BWAY

NASDAQ

BrainsWay Ltd.

$11.42 −3.30% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
63 sessions
$18 $10 21 Jul 16 Oct

The line runs $16.21 on 21 July through $11.42 on 16 October, on a scale from $10 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 21 Jul – 16 Oct 2026
52-week range $7.41 – $17
Avg volume 6.0K

as of Oct 16, 2026

Filings 1 set

BWAY institutional holders

SEC Form 13F SEC EDGAR

5 of the 45 institutional funds we track reported a BWAY position for the quarter ended 30 Jun 2026 — a combined $12.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −8.2% shares 475,920 $7.4M
ARK Investment Management Trimmed −26.4% shares 142,500 $2.2M
Two Sigma Investments Held (±25%) −22.3% shares 99,545 $1.5M
Citadel Advisors Trimmed −45.4% shares 47,519 $737K
Man Group Held (±25%) +0.9% shares 27,474 $426K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR 13F filings